[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiopharmIQ BiopharmIQ by Amp

Several biotech companies have recently made significant announcements, including $INBX, which saw a XX% increase in stock value after releasing positive topline results for its chondrosarcoma trial. $RNA entered into an acquisition agreement for $XX billion, and $NVS is set to acquire $RNA's neuro pipeline. Additionally, $GMAB is acquiring $MRUS for $X billion, expanding its portfolio with a phase X bispecific petosemtamab.

Engagements: XXXXX #

X Week XXXXXX +52%
X Month XXXXXXX -XX%
X Months XXXXXXXXX +20%
X Year XXXXXXXXX -XX%

Mentions: XX #

X Week XX +12%
X Month XXX -XX%
X Months XXX -XX%
X Year XXXXX -XX%

Followers: XXXXXX #

X Week XXXXXX +0.59%
X Month XXXXXX +1.60%
X Months XXXXXX +14%
X Year XXXXXX +23%

CreatorRank: XXXXXXX #

Social Influence

Social category influence stocks XXXXX% cryptocurrencies #3939 finance XXXXX% countries XXXX% exchanges XXXX% technology brands XXXX% currencies XXXX%

Social topic influence $gpcr #5, $xcur #2, $aclx #1, $iron #1, $ewtx #1, $nktr #4, $incy #1, $argx #2, $rytm #4, $insm #2

Top accounts mentioned or mentioned by @yaireinhorn @bowtiedbiotech @bowtiedbiotechs @amaymd @biotech2k1 @geneinvesting @pharmdca @bioinvestor24 @learnbiotech @andreagtc @drsamuelbhume @ohadhammer @hatedmoats @seedy19tron @lifescivc @desertdweller93 @biostocks @aaronrosenblum5 @crisprtx @rheumatdocx

Top Social Posts

Top posts by engagements in the last XX hours

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $LGVN Phase 2a $INMB Phase X $AVXL Phase 2/3 $STOK Phase X $ACLX Phase X $IRON Phase X $GLPG Phase X $NRIX Phase X $XCUR Phase X $PVLA Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $BHVN Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $HOOK Phase X $AMGN Phase X $INCY Phase X $BINV"
X Link 2025-11-30T21:25Z 28.1K followers, 73.9K engagements

"📌 Biotech Stock News 12/9 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"
X Link 2025-12-10T16:17Z 28.1K followers, 2731 engagements

"100% approval month 💥 Every drug/PDUFA in Oct got approved $JAZZ Zepzelca + Tecentriq $ARQT ZORYVE (roflumilast) Cream XXXX% $AMGN Tezspire $GKOS Epioxa (Epi-on) $GSK Blenrep combinations (BVd & BPd) $SNDX Revuforj (revumenib) $MRK WINREVAIR (sotatercept-csrk) $RHHBY Gazyva/Gazyvaro $REGN Libtayo (cemiplimab) Updated calendar below"
X Link 2025-11-03T20:39Z 28.1K followers, 24.5K engagements

"Perceptive Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $RYTM (7.1%) $ASND (6.2%) $ACLX (5.9%) $CELC (4.2%) $NUVL (3.9%) $MRUS (3.7%) $AMLX (3.5%) $ROIV (3.2%) $MGTX (3%) $INSM (2.9%) $TVTX (2.6%) $AORT (2.5%) $PRAX (2.4%) $IMTX (2.3%) $CNTA (2.2%) $SLDB (2.1%) $PTGX (2%) $NBIX (1.8%) $EWTX (1.8%) $VRNA (1.6%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link 2025-11-14T23:56Z 28.1K followers, 4957 engagements

"🧬 Biotech Stock News 12/01 @ Open $QTTB XXX% Sells Complement Inhibitor ADX-097 $MAIA XX% Open Market Purchases by CEO & Directors $BLTE X% Positive Results from Phase X Trial $PMN X% New Publication on Plasma pTau in Alzheimer's $RDHL X% Regains Compliance with Nasdaq $OMER X% Closing of Asset Purchase Agreement $AAPG X% Webcast Highlighting Key Data from ASH 2025 $BMY X% Data Showcase Hematology Pipeline Potential $VTRS X% Seeking Partnerships for Long-Acting Depot Drugs $MIRM X% First Patient Enrolled in BLOOM Study $MNKD -X% FDA Review of FUROSCIX Autoinjector $BCDA -X% Present at Heart"
X Link 2025-12-01T15:51Z 28.1K followers, 6295 engagements

"December Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $AXGN - Avance Nerve Graft - Approved $BMY - Breyanzi (lisocabtagene maraleucel) - Approved $AGIO - PYRUKYND (Mitapivat) $GSK - BLUJEPA (gepotidacin) $BCRX - ORLADEYO (berotralstat) Oral Granules $MIST - CARDAMYST (etripamil) nasal spray $INVA - Zoliflodacin $ALDX - Reproxalap $GSK - Depemokimab $OMER - Narsoplimab (OMS721) $CYTK - Aficamten $SNY - Tolebrutinib $CORT - Korlym (Relacorilant) $VNDA - Tradipitant $OTLK - ONS-5010 / LYTENAVA (bevacizumab-vikg) $TEVA - TVB-009P (denosumab) $ALVO - AVT06 proposed biosimilar to Eylea"
X Link 2025-12-05T16:48Z 28.1K followers, 49.2K engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $GPCR Aleniglipron (GSBR-1290) $VTGN Fasedienol (PH94B) $ZBIO Obexelimab (CD19xFcyRIIb) Access our FREE Big Mover Report"
X Link 2025-12-07T21:27Z 28.1K followers, 2037 engagements

"🩸 ASH 2025 continues ending tomorrow Here are the presentations pulled from todays news: $FULC XX% Positive Results from PIONEER Trial $NRIX XX% New Data from Phase X Trial $NRIX XX% New Data on Bexobrutideg in CLL $CGEM XX% Clinical Data in AML Presentation $ACLX X% New Positive Data for iMMagine-1 Study $LYEL X% New Clinical Data on Ronde-Cel $EVAX X% New data for cancer vaccine candidate $AUTL X% Initial Clinical Data in Pediatric r/r B-ALL $ALXO X% Positive Results from Phase X Trial $ARVN X% Preclinical Data on ARV-393 and Glofitamab $IRON X% Positive Data from RALLY-MF Trial $SLS 3%"
X Link 2025-12-08T17:29Z 28.1K followers, 4857 engagements

"$XCUR up XX% 📈 Burixafor Ph2: MM mobilization XX% achieved primary endpoint goal Safe with daratumumab-exposed patients Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"
X Link 2025-12-10T16:17Z 28.1K followers, XXX engagements

"📌 Biotech Stock News 12/10 @ Open $TERN XX% $650M Offering $DYN X% $350M Public Offering $BRNS X% VTP-1000 Trial Update $MDWD X% Clinical Data on NexoBrid's Effectiveness $GPCR X% Pricing of $650M Offering $SGMT X% Denifanstat NDA Accepted by China NMPA $PTCT X% Health Canada Approves Sephience $ALC X% Response to Increased Acquisition Price $LXRX X% ACSL5 Preclinical Data Publucation $PFE X% TUKYSA Extends Survival 8mths $LLY X% Build $6B facility in Alabama $KYMR X% $602M Offering $AMRX X% Epinephrine Injection FDA Approval $NCNA -X% NUC-7738 Latest Data $PRAX -X% Elsunersen Accelerated"
X Link 2025-12-10T16:32Z 28.1K followers, 1595 engagements

"🧬 Biotech Stock News 08/19 Brought to you by Barb X stocks on the rise 📈 $EVFM $IOVA $PTCT X under pressure 📉 $ALXO $BTAI $VKTX Catch the full breakdown in the latest video 🎥"
X Link 2025-08-19T17:09Z 28.1K followers, 3860 engagements

"🧬 Biotech Stock News 9/5 @ Open $ADAG X% ADG126 Highlighted at CSCO Meeting $HCM X% Clinical Data Presentation at CSCO $CGON X% 24-month Durability and Tolerability Data $MLYS X% Subgroup Analyses of Ph3 Trial $MLYS X% Closing of $287.5M Offering $RGNX X% 12-month Pivotal Data from RGX-121 Trial $AVDL X% New Data on LUMRYZ $GILD X% Partnership for HIV Prevention Initiative $MDT X% Robotic Surgery System Meets Safety Endpoints $RHHBY X% New Data on Vabysmo for Wet AMD $THTX X% Availability of EGRIFTA WR for Injection $QURE X% Initial AMT-191 Phase 1/2a Data $AMRX -X% FDA Approval for"
X Link 2025-09-05T16:59Z 28.1K followers, 6762 engagements

"📌 Biotech Stock News 09/17 @ Open $ROIV XX% Brepocitinib Ph3 Study Results $ORKA XX% ORKA-001 Interim Ph1 Results $ELTX X% ELI-002 Trial Update $ATXS X% Ph1a Trial Initial Results $NRIX X% Preclin Data on IRAK4 Degrader $AKTX X% New Patent Filing for ADC Platform $ARQT X% New ZORYVE Data Analyses $TNXP X% In-licensing of TNX-4800 $XFOR X% Restructuring of Business Operations $CLDX X% Barzolvolimab Data at EADV $PTGX X% PN-881 Data at EADV $CDTX X% CD388 Ph2b Data $CADL X% Ph3 Results of CAN-2409 $VTRS X% First Patient Recruited in Ph2/3 Study $REGN X% Ph2 Trial Results on GLP-1 Receptor"
X Link 2025-09-17T17:00Z 28.1K followers, 9354 engagements

"📌 Biotech Stock News 09/26 @ Open $CRNX XX% FDA Approval of PALSONIFY for Acromegaly $GUTS XX% REMAIN-1 Midpoint Cohort Data $AMRX X% BLA Submission of Xolair Biosimilar $SNY X% Expands Patient Affordability Program $KALV X% New EKTERLY Data at Allergy Congress $CDTX X% First Participants Dosed in Ph3 Trial $KURA X% Publication of Ziftomenib Data in AML $LLY X% Marketing Authorization for Alzheimer's treatment $LLY X% FDA Approves Inluriyo for Breast Cancer $ABBV X% NDA Submission for Tavapadon $THTX X% Completion of Acquisition by Future Pak $AMGN X% $650M U.S. Manufacturing Expansion $REGN"
X Link 2025-09-26T16:12Z 28.1K followers, 7246 engagements

"🧬 Biotech Stock News 09/26 Brought to you by Barb On the rise 📈 $CRNX XX% $GUTS XX% $AMRX X% Under pressure 📉 $AMGN -X% $REGN -X% $QURE -X% Catch the full breakdown in the latest video"
X Link 2025-09-26T18:18Z 28.1K followers, 3254 engagements

"📢 M&A News: Ipsen $IPSEY to acquire ImCheck Therapeutics for 1B 💵 350M upfront + milestones up to 1B; 🔬 ICT01: BTN3A-targeting antibody in Ph2/3 asset for first-line unfit AML 2x higher response rates vs. historical Ven-Aza standard 🗓 Transaction is expected to close by the end of Q1 2026; pivotal trial planned for 2026. See image for more details 👇"
X Link 2025-10-22T14:25Z 28.1K followers, 6446 engagements

"📢 M&A News: $LLY to Acquire $ADVM $3.56/sh upfront + up to $8.91/sh CVR valuing the deal at up to $1.3B Adds Ixo-vec a one-time intravitreal gene therapy for wet AMD Ph3 (ARTEMIS trial) with Fast Track RMAT and PRIME designations $LLY provided $65M bridge financing to fund ongoing trials ahead of deal close in Q4 2025 See images for more details 👇"
X Link 2025-10-24T14:14Z 28.1K followers, 3685 engagements

"🧬 Biopharma Weekly Recap 📝 This week in biotech: Biotech week spotlighted ADC momentum big win for $VTYX fresh FDA approvals and renewed investor buzz around gene editing and undervalued small caps. See interesting posts/ppl to check out 👇 @RheumatDocX 🧬 Monoclonal Antibody Nomenclature (WHO 2021 Update) @yaireinhorn This excellent piece by WSJs @DrSamuelBHume X breakthroughs in medicine this week @PersimmonTI A Visual History of Approved ADCs @ohadhammer Similar story in SCLC with ADCs targeting B7H3 DLL3 SEZ6 all reporting. @HatedMoats 🚨 Novo News - FDA approval ✅ @BowTiedBiotech ESMO"
X Link 2025-10-25T16:23Z 28.1K followers, 15.7K engagements

"How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above 🤔 $RVMD 12/34 $ZLAB 4/34 $LXEO 4/34 $VKTX 4/34 $VTYX 3/34 $IPSC 2/34 $SMMT 1/34 $NTLA 1/34 Access our FREE screener to check your fave stocks 👇"
X Link 2025-10-25T16:23Z 28.1K followers, 1885 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $PHVS Phase X $VTGN Phase X $ZBIO Phase X $INBX Phase 2/3 $MLTX Phase X $ANAB Phase X $BLTE Phase X $ADVM Phase X $MBRX Phase X $ENGN Phase X $CTNM Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $ATOS Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $IRON Phase X $ADCT Phase X $AGIO Phase X $SLS Phase X $PCVX Phase X $ALZN Phase X $ACLX Phase X $ELDN Phase X $BIVI Phase 2b $KPTI Phase X $CRVS Phase X Check out the image for more details"
X Link 2025-10-26T19:50Z 28.1K followers, 1435 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $ADVM Ixoberogene soroparvovec (Ixo-vec) $VTGN Fasedienol (PH94B) $MREO Setrusumab (UX143) Access our FREE Big Mover Report"
X Link 2025-10-26T19:50Z 28.1K followers, 2516 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $ADVM 3/34 $VTGN 2/34 $MREO 1/34 Access our FREE hedge fund screener & search your fav tickers"
X Link 2025-10-26T19:50Z 28.1K followers, 2557 engagements

"📌 Biotech Stock News 11/7 @ Open $THAR XX% Closes $545M Private Placement $BCAB X% Median OS of XXXX months in Sarcomas $AKBA X% Vafseo Post Hoc Data $HALO X% FDA Approves DARZALEX Faspro $AZN X% NATRON Ph3 trial results $CNTX X% CT-95 and CT-202 Programs $ELTX X% Cytolytic T Cell Responses in Trial $TMO X% Authorizes $5B Share Repurchases $MIRM X% Leadership in Liver Disease Innovation $AKRO X% New Analyses from Ph2b Trials $IMCR X% Ph1 data for hepatitis B $INKT X% Durable Responses with Allo-iNKT Tx $HCWB X% Preclinical Data @ SITC'25 $JNJ X% First FDA-approved treatment for myeloma $ASMB"
X Link 2025-11-07T16:12Z 28.1K followers, 2784 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $IFRX Phase 2a $IFRX Phase 2b $VRCA Phase X $KZR Phase 2a $CRDL Phase X $ARTV Phase 2a $ACLX Phase X $IRON Phase X $NUVL Phase X $XCUR Phase X $PVLA Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT"
X Link 2025-11-09T19:44Z 28.1K followers, 33.9K engagements

"$DAWN $MRSN 🔥 Day One Biopharmaceuticals is set to acquire Mersana Therapeutics - deal worth up to $285M - shareholders receive $25/sh cash upfront plus up to $30.25/sh potential CVR - payouts tied to key milestones for Emi-Le & an existing collaboration MRSN lead asset: - Emi-Le is a B7-H4directed Dolasynthen ADC being developed for triple-negative breast cancer & adenoid cystic carcinoma - closing expected by Jan 2026"
X Link 2025-11-13T15:24Z 28.1K followers, 6263 engagements

"Avoro Capital 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ASND $UTHR $MDGL $ARGX $KRYS $ARWR $KYMR $MRUS $RNA $APLS $CNTA $QURE $XENE $AKRO $VERA $SLNO $GPCR $TRML $OCUL $FOLD *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link 2025-11-14T16:23Z 28.1K followers, 7395 engagements

"OrbiMed Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XXX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXX% Top Holdings: $EWTX (5.9%) $BSX (5.6%) $LLY (5.4%) $SINX (4.3%) $ELVN (3.8%) $ALNY (3.2%) $SYK (3.1%) $EW (3.1%) $ISRG (3.0%) $ARGX (3.0%) $SION (2.6%) $UPB (2.5%) $IRON (2.2%) $CAI (2.2%) $SPRY (2.0%) $RNA (1.7%) $MBX (1.6%) $CGON (1.6%) $NTRA (1.6%) $AXSM (1.5%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details👇"
X Link 2025-11-14T23:00Z 28.1K followers, 9250 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $INAB Phase X $CRDL Phase X $ACLX Phase X $IRON Phase X $NUVL Phase X $XCUR Phase X $STOK Phase X $GLPG Phase X $NRIX Phase X $PVLA Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $ARGX Phase X $INCY Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $PRAX Phase 2/3 $BHVN Phase X $ZNTL Phase X $IOVA Phase X $GNLX Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK"
X Link 2025-11-16T20:34Z 28.1K followers, 31.3K engagements

"📌 Biotech Stock News 11/25 @ Open $AUTL XX% Treatment Option for R/R B-ALL $CTXR X% Exhibit at ASH Annual Meeting $BIIB X% Completes Rolling Submission for LEQEMBI $XENE X% New Azetukalner OLE Study Data $LLY X% Data from Phase X studies presented $BMY X% Approval to Expand CAR T Therapy $RAPP X% New Phase 2a Data Analysis $SRPT X% Approval for ENDEAVOR Cohort X $REGN X% First Targeted Medicine Approved for CSU $TLSA X% Nasal Foralumab Phase X Trial Accepted $TEVA X% EU Commission approvals for biosimilars $TELO X% New Data Reduces PSA Levels $NVCT -X% Virtual Meeting on NXP900 Program $NUVL"
X Link 2025-11-25T17:13Z 28.1K followers, 2504 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/2). $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $PRAX Phase X $INBX Phase 2/3 $MLTX Phase X $BLTE Phase X $ADVM Phase X $ALT Phase 2b $RYTM Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $SLS Phase X $PCVX Phase X $IMMP Phase 2/3 $ALDX Phase X $ALNY Phase X $LLY Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS"
X Link 2025-11-30T21:25Z 28.1K followers, 1487 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IRON DISC-0974 $NKTR Rezpegaldesleukin (NKTR-358) $MGNX Lorigerlimab + docetaxel Access our FREE Big Mover Report"
X Link 2025-11-30T21:25Z 28.1K followers, 3266 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $IRON 10/34 🔥 $NKTR 6/34 $MGNX 3/34 Access our FREE hedge fund screener & search your fav tickers"
X Link 2025-11-30T21:25Z 28.1K followers, 2411 engagements

"📌 Biotech Stock News 12/2 @ Open $NRXP X% FDA Receives ANDA for KETAFREE $JSPR X% ETESIAN Study Positive Data $TLSA X% Plans to Spinout IL-6 Asset $SGMO X% FDA Fast Track for ST-503 $PDSB X% Scheduling of Type C Meeting with FDA $RHHBY X% FDA Clearance for Point-of-Care Test $BFRI X% Filing of sNDA for sBCC Treatment $ARWR X% Plozasiran Breakthrough Tx Designation $ENGN X% Detalimogene Selected for FDA Pilot $PCRX X% 12-Month Study Shows Pain Improvement $LGVN X% Granted Patent for Stem Cell Method $HRMY X% New Data from Phase X ARGUS Trial $NTRA X% Presenting XX Datasets at Symposium $JAGX"
X Link 2025-12-02T16:48Z 28.1K followers, 4053 engagements

"$JANX down -XX% 📉 JANX007 showed 8-month RPFS in mCRPC PSA drops and partial responses reported CRS mainly grade XX and seen early in treatment Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"
X Link 2025-12-02T16:48Z 28.1K followers, 1138 engagements

"📣 Join our Biotech Daily Stock Moves community. 📌 hottest headlines 🔥 📌 stock moves 📈📉 Stay informed and make smarter investing Visit the link to join our community.👇"
X Link 2025-12-02T16:48Z 28.1K followers, 1030 engagements

"🧬 Biotech Weekly News Largest single-day stock moves during the week ending 12/5/25 📈 $CAPR XXX% Deramiocel Topline Results Reported $QTTB XX% Sells Complement Inhibitor ADX-097 $PRAX XX% Relutrigine Results; Ulixacaltamide Pre-NDA Mtg. $PHVS XX% Deucrictibant Topline Data Reported $GUTS XX% Positive 6-Month REVEAL-1 Results 📉 $JANX -XX% Ph1 JANX007 Efficacy & Safety Profile $BDTX -XX% Silevertinib Preliminary Ph2 Data $CLNN -XX% CNM-Au8 ALS Biomarker Results $TARA -XX% Pricing of $75M Offering $SPRC -XX% Entering Multi-Billion-Dollar GERD Device Market"
X Link 2025-12-05T22:17Z 28.1K followers, 12.4K engagements

"Check out our catalyst calendar 📅 & stay on top of key biopharma readouts $XBI $IBB"
X Link 2025-12-05T23:16Z 28.1K followers, 1228 engagements

"Check out this week's biotech major movers $XBI $IBB"
X Link 2025-12-06T15:02Z 28.1K followers, 1781 engagements

"📌 Biotech Stock News 12/10 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"
X Link 2025-12-09T16:40Z 28.1K followers, 3596 engagements

"November Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $ARWR - Plozasiran (ARO-APOC3) $KURA - Ziftomenib $ASND - TransCon CNP See this months PDUFA calendar below"
X Link 2025-11-03T22:23Z 28.1K followers, 40.8K engagements

"$AXGN 🎉 FDA approves BLA for AVANCE (acellular nerve allograftarwx) - AVANCE is now an FDA-licensed biologic for sensory mixed and motor peripheral nerve discontinuities in patients X month old - some indications granted under Accelerated Approval; confirmatory studies to follow - commercial launch in Q2 2026"
X Link 2025-12-04T14:42Z 28.1K followers, 9289 engagements

"📣 Biotech Stock News 12/04 @ Open $AXGN XX% FDA Approves of BLA for AVANCE $BIOA XX% Positive Interim Ph1 Data for BGE-102 $ABSI X% First Participants Dosed in Trial $PTHS X% Major Pharmacy Benefit Manager Agreement $PPBT X% New Preclinical Data at ESMO-IO 2025 $INTS X% Two Presentations at Breast Cancer Symposium $APLS X% Positive Phase X Results for C3G $BFRI X% Last Patient Completes Phase X Study $CATX X% Acceptance of VMT--NET Data for Presentation $ORIC X% Late-Breaking Oral Presentations at ESMO $ENLV X% Fireside Chat on RAIN Token Strategy $PSTV X% Highlights Three REYOBIQ Clinical"
X Link 2025-12-04T15:28Z 28.1K followers, 4937 engagements

"🧬 Biopharma Weekly Recap 📝 This week in biotech: China dealmaking surges obesity programs and competitive dynamics intensify FDA shifts spotlight reviews and rare disease and cell therapy updates drive focus. See interesting posts/ppl to check out 👇 @Biotech2k1 Biotech Forever X names cited with high sales estimates ($INSM $BBIO $AXSM $CRNX $CYTK $PTXG $IDYA $COGT); outlook noted as subject to change. @ohadhammer Jefferies: China biotech showing record activity and R&D productivity; key issue is program differentiation. @PearlF An updated FDA org chart from @biospace @DrSamuelBHume 5"
X Link 2025-12-06T15:00Z 28.1K followers, 26.6K engagements

"RA Capital 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ASND (25.0%) $RYTM (7.1%) $PCVX (5.3%) $RNA (4.6%) $CDTX (4.0%) $SION (3.8%) $ETNB (3.6%) $NAMS (3.6%) $MLYS (3.4%) $JANX (3.4%) $ACLX (3.1%) $LENZ (2.4%) $TYRA (2.1%) $EWTX (2.1%) $WVE (1.6%) $SEPN (1.6%) $DNTH (1.4%) $BCAX (1.4%) $GHRS (1.4%) $SPRY (1.3%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link 2025-11-14T22:38Z 28.1K followers, 9504 engagements

"Baker Brothers Advisors 🔔 🐳 Q3 25* Holdings Released Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: XXXXX% Top Holdings: $ONC (22%) $INCY (19%) $MDGL (7.1%) $INSM (7%) $ACAD (6.6%) $SMMT (5%) $RYTM (4.1%) $RVMD (3.2%) $CELC (2.8%) $KYMR (2.7%) $KOD (2%) $ALKS (1.8%) $ABCL (1%) $EWTX (0.9%) $KNSA (0.8%) $STOK (0.8%) $IMTX (0.7%) $GRAL (0.7%) $IDYA (0.6%) $IMVT (0.6%) *Holdings as of 9/30/25 in SEC form 13F **Change in value of public company shares held"
X Link 2025-11-14T23:19Z 28.1K followers, 19.8K engagements

"December Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $AXGN - Avance Nerve Graft - Approved ✅ $BMY - Breyanzi (lisocabtagene maraleucel) $AGIO - PYRUKYND (Mitapivat) $GSK - BLUJEPA (gepotidacin) $BCRX - ORLADEYO (berotralstat) Oral Granules $MIST - CARDAMYST (etripamil) nasal spray $INVA - Zoliflodacin $ALDX - Reproxalap $GSK - Depemokimab $OMER - Narsoplimab (OMS721) $CYTK - Aficamten $SNY - Tolebrutinib $CORT - Korlym (Relacorilant) $VNDA - Tradipitant $OTLK - ONS-5010 / LYTENAVA (bevacizumab-vikg) $TEVA - TVB-009P (denosumab) $ALVO - AVT06 proposed biosimilar to Eylea (aflibercept) $AMRX"
X Link 2025-12-04T16:53Z 28.1K followers, 8094 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $STOK Phase X $HRMY Phase X $RXRX Phase X $XCUR Phase X $IMMP Phase 2/3 $PVLA Phase X $LTRN Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $SLS Phase X $MGTX Phase X $IDYA Phase 2/3 $DWTX Phase 2b $WVE Phase X $EWTX Phase X $ZYME Phase X $ZVSA Phase 2a $BHVN Phase X $VTYX Phase X $DBVT Phase X $VTGN Phase X $INBX Phase 2/3 $LSTA Phase 2a $ADVM Phase X $ALT Phase 2b $ACIU Phase X $RYTM Phase X $ATOS Phase 2"
X Link 2025-12-07T21:27Z 28.1K followers, 39.3K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/2). $GNLX Phase X $EXEL Phase X $PCSA Phase X $BMEA Phase X $EXEL Phase X $HOOK Phase X $AMGN Phase X $INCY Phase X $BINV Phase 2a $ALDX Phase X $ALNY Phase X $LLY Phase X $FBIO Phase X $MRNA Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $GNFT Phase X $NAMS Phase X $KZIA Phase X $NVS Phase X $NAMS Phase X $DNLI Phase 2/3 $INKT Phase X $ADAG Phase X $CNTA Phase 2a $NAMS Phase X $CRVS Phase X $BIVI Phase 2b Check out the image for more details"
X Link 2025-12-07T21:27Z 28.1K followers, XXX engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $GPCR 14/34 🔥 $VTGN 4/34 $ZBIO 3/34 Access our FREE hedge fund screener & search your fav tickers"
X Link 2025-12-07T21:27Z 28.1K followers, 1845 engagements

"📣 Biotech Stock News 12/11 @ Open $RYTM XX% Setmelanotide shows positive efficacy $RNAZ XX% Ph2a trial with TTX-MC138 $ACIU XX% Positive Ph2 Data on ACI-7104.056 $OKYO XX% New data for neuropathic corneal pain $ATOS XX% FDA Designation for (Z)-Endoxifen $BYSI XX% Survival Benefit of Plinabulin + Docetaxel $BHVN XX% Clinical data for BHV-1510 & Cemiplimab $GERN X% Strategic Restructuring Plan Announced $ADXN X% Amends at the Market Offering $MAIA X% First Patient Dosed in THIO-104 Trial; Insider Buying and Trial Data $AARD X% First Patient Dosed in HERO Trial $CVKD X% Acquires VLX-1005 for"
X Link 2025-12-11T16:09Z 28.1K followers, 4190 engagements